GL1X · GenesisL1 explorer

Research workbench

Crystal structure of SPF45 uhm domain with cyclic peptide inhibitor

Analyse Crystal structure of SPF45 uhm domain with cyclic peptide inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5LSO
Type
protein
Length
218 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Splicing factor 45; Lys-ser-arg-TRP-asp-glu
UniProt
Q96I25

Structure

x-ray diffraction · 2 distinct chains · 26% helix, 28% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BSplicing factor 45protein10327% helix, 28% strandQ96I25
C, DLys-ser-arg-TRP-asp-gluprotein60% helix, 17% strand—

Interfaces

4 interfaces between chains.

  • A–C · 443 Ų buried · 15 hydrogen bonds · protein-protein
  • B–D · 430 Ų buried · 13 hydrogen bonds · protein-protein
  • A–B · 343 Ų buried · 4 hydrogen bonds · protein-protein
  • C–B · 82 Ų buried · 1 hydrogen bond · protein-protein

Modifications

Observed in the structure: 2 isopeptide (isopeptide).

Compared structures

  • 5LSO · Crystal structure of SPF45 UHM domain with cyclic peptide inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • Q96I25 · AlphaFold monomer V2.0 prediction for splicing factor 45 (Q96I25) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.